Replies to post #204977 on Biotech Values

[DewDiligence]

KMDA -8%—SHPG dumps AAT program in GvHD:

https://globenewswire.com/news-release/2017/06/07/1009259/0/en/Kamada-Provides-Update-on-Clinical-Program-for-Alpha-1-Antitrypsin-IV-for-Treatment-of-Graft-Versus-Host-Disease.html